Statistics

Total Visits

Views
Long-Term (104 Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials77

Select a period of time:

Number of views in the range

Views
Long-Term (104 Week) Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pooled Safety Analysis of Three Phase III, Randomized, Controlled Trials29

Views

Views
May 20250
June 20250
July 202519
August 20251
September 20255
October 20252
November 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil11
United States7
United Kingdom3
Austria1
Costa Rica1
Ecuador1
Ethiopia1
Mexico1
Paraguay1
Turkey1
 

Top cities views

Views
São Paulo2
Dallas2
Adana1
Addis Ababa1
Ashburn1
Asunción1
Brasília1
Dourados1
Durban1
Erval Grande1